Eugene Schneider
CIK 1838539 · EVP, Chf Clinical Develop Ofcr · last filed 2026-03-23
Eugene Schneider is an EVP, Chf Clinical Develop Ofcr who has filed 40 SEC Form 4 insider transactions across 1 company since 2021. The most recent filing, for IONS, was dated Jun 26, 2026. Across all open-market trades the lifetime net is −$5.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.40M
1
40
-$5.94M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IONS | EVP, Chf Clinical Develop Ofcr | 63,890 | $53.26 | $3.40M | -$5.94M | 26 | 2026-03-23 |
Recent Filings
40 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-26 | IONS | Notice (144) | −47,884 | -$3.88M | EDGAR |
| 2026-03-24 | IONS | Notice (144/A) | −5,812 | -$412.5K | EDGAR |
| 2026-03-23 | IONS | Sell (S) | −5,812 | -$412.5K | EDGAR |
| 2026-03-19 | IONS | Notice (144) | −5,812 | -$412.5K | EDGAR |
| 2026-02-02 | IONS | Mixed | +5,812 | -$515.6K | EDGAR |
| 2026-01-30 | IONS | Notice (144) | −6,179 | -$512.9K | EDGAR |
| 2026-01-20 | IONS | Mixed | +12,383 | -$703.1K | EDGAR |
| 2026-01-16 | IONS | Notice (144) | −9,302 | -$709.1K | EDGAR |
| 2026-01-06 | IONS | Grant (A) | — | $0 | EDGAR |
| 2025-09-04 | IONS | Mixed | — | -$138.4K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.